Abstract:
This talk will present current health communication research on improving access to and utilization of cancer genetic services in various clinical contexts. The focus will be on how health technology approaches may address – or widen – disparities in utilization by patients across subgroups defined by race, ethnicity, language preference, health literacy, and gender. Future research directions will be discussed.

Date: Tuesday, January 17, 2023
Time: 12pm - 1pm ET
Register in Advance for This Meeting:
https://mssm.zoom.us/meeting/register/tZcodequqzIqHNxRgwGF6j4dKMMOBT-_c5hF

Speaker:
Kimberly Kaphingst, ScD, is a Professor in the Department of Communication and the Director of Cancer Communication Research at the Huntsman Cancer Institute at the University of Utah. She is also a member of the Utah Center for Excellence in ELSI Research. Dr. Kaphingst's research interests are in health literacy, genetic literacy, and health communication. She has worked in the area of health literacy for more than 20 years, examining health literacy in various contexts. A major focus is health literacy and health communication research in the context of genetic and genomic information, examining patient responses to genetic test results and individuals’ preferences for return of genetic information. Dr. Kaphingst currently serves as a Principal Investigator for the BRIDGE multi-site randomized trial funded through the National Cancer Institute's Inherited Cancer Syndromes Collaborative, which is examining a communication technology-based approach for delivering cancer genetic services to primary care patients.